| Product NDC: | 0135-0077 |
| Proprietary Name: | VIVARIN |
| Non Proprietary Name: | caffeine |
| Active Ingredient(s): | 200 mg/1 & nbsp; caffeine |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0135-0077 |
| Labeler Name: | GlaxoSmithKline Consumer Healthcare LP |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | part340 |
| Marketing Category: | OTC MONOGRAPH FINAL |
| Start Marketing Date: | 20101108 |
| Package NDC: | 0135-0077-07 |
| Package Description: | 16 TABLET in 1 BLISTER PACK (0135-0077-07) |
| NDC Code | 0135-0077-07 |
| Proprietary Name | VIVARIN |
| Package Description | 16 TABLET in 1 BLISTER PACK (0135-0077-07) |
| Product NDC | 0135-0077 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | caffeine |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20101108 |
| Marketing Category Name | OTC MONOGRAPH FINAL |
| Labeler Name | GlaxoSmithKline Consumer Healthcare LP |
| Substance Name | CAFFEINE |
| Strength Number | 200 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes |